What the research shows
- AOD-9604: no IGF-1 rise in human trials
- Fragment 176-191: studied for fat metabolism in mice
- Fragment 176-191: studied for fat breakdown in fat tissue
Published study results for the compound, not results from this product. For research use only.
This equal-mass 3mL formulation is catalogued as 25mg HGH Fragment (176-191) plus 25mg AOD-9604. The photographed pack states only Fragment + AOD-9604 and does not establish the fragment boundary or either sequence; the catalogued components are related but non-identical C-terminal growth-hormone-derived sequences. No evidence for a distinct fixed-combination effect is supplied. No batch-specific independent report is linked, so component identity, quantity and purity are unverified.
- Pack Size
- 3mL
- Product details
- Genovare Catalogue
- Pre-Filled Pen
- Premixed Aqueous
- Storage Guidance
- Follow Package Label
- 1 pre-filled Genovare research pen
- 3 pen needles
- Genovare retail packaging
Genovare Pre-Filled Pen Premixed Aqueous
SpecsHGH Fragment (176-191) + AOD-9604 50mg Total (25mg + 25mg) AQ Pen
AOD-9604: placebo-like safety in six human trials
AED 1,100 / pen
Choose your bundle
Minimum order is AED 400
25% off orders of AED 700+ with code KV25 at checkout
Order before 4 PM for same-day Dubai delivery.
UAE delivery: AED 50 below AED 1,000; free from AED 1,000
- Sold by
- Remy Research
- Brand
- Genovare
- Manufacturer
- Genovare
- Tested by
- Independent testing not supplied
Ships from Dubai
Technical Specifications
| Manufacturer | Genovare |
|---|---|
| Compound | HGH Fragment (176-191) + AOD-9604 |
| Catalogue strength | 50 mg total (25 mg + 25 mg) |
| Fill volume | 3mL |
| Format | Aqueous pre-filled pen |
| Pack size | 1 pen with 3 needles |
| Independent testing | Not supplied |